Contact
searchSearch
HMP Global

News

Psoriasis on hand
News
Italian Dermatologists Propose Practical Criteria to Define Moderate Psoriasis
11/03/2026
Jessica Garlewicz
A panel of Italian dermatologists proposed practical criteria for defining moderate psoriasis, emphasizing the importance of combining objective severity measures with patient-reported outcomes to improve treatment selection and reduce...
A panel of Italian dermatologists proposed practical criteria for defining moderate psoriasis, emphasizing the importance of combining objective severity measures with patient-reported outcomes to improve treatment selection and reduce...
A panel of Italian...
11/03/2026
The Dermatologist
Physician talk with overweight man
News
Psoriasis and Obesity Share Inflammatory Pathways, Highlighting Need for Integrated Care
11/03/2026
Jessica Garlewicz
Psoriasis and obesity share inflammatory pathways that may contribute to greater disease severity, reduced treatment response, and increased metabolic complications.
Psoriasis and obesity share inflammatory pathways that may contribute to greater disease severity, reduced treatment response, and increased metabolic complications.
Psoriasis and obesity share...
11/03/2026
The Dermatologist
Scientist in lab
News
Single-Cell and Spatial Transcriptomics Reveal New Insights Into Psoriasis Pathogenesis
11/03/2026
Jessica Garlewicz
Advances in single-cell RNA sequencing and spatial transcriptomics are reshaping understanding of psoriasis pathogenesis, highlighting the role of cellular interactions and tissue microenvironments in disease heterogeneity.
Advances in single-cell RNA sequencing and spatial transcriptomics are reshaping understanding of psoriasis pathogenesis, highlighting the role of cellular interactions and tissue microenvironments in disease heterogeneity.
Advances in single-cell RNA...
11/03/2026
The Dermatologist
Psoriasis on foot
News
Psoriasis-Atopic Dermatitis Overlap Phenotype Presents Diagnostic and Therapeutic Challenges
11/03/2026
Jessica Garlewicz
Patients exhibiting overlapping features of psoriasis and atopic dermatitis may present distinct diagnostic and therapeutic challenges due to mixed inflammatory pathways.
Patients exhibiting overlapping features of psoriasis and atopic dermatitis may present distinct diagnostic and therapeutic challenges due to mixed inflammatory pathways.
Patients exhibiting overlapping...
11/03/2026
The Dermatologist
Physician with dermatoscope
News
Dermoscopy With UV Imaging May Help Differentiate Mycosis Fungoides, Psoriasis, and Atopic Dermatitis
11/03/2026
Jessica Garlewicz
Dermoscopy combined with ultraviolet imaging may help distinguish early-stage mycosis fungoides, psoriasis, and atopic dermatitis.
Dermoscopy combined with ultraviolet imaging may help distinguish early-stage mycosis fungoides, psoriasis, and atopic dermatitis.
Dermoscopy combined with...
11/03/2026
The Dermatologist
Atopic dermatitis
News
Emerging Biomarkers May Improve Precision Diagnosis and Personalized Treatment in Atopic Dermatitis
11/03/2026
Jessica Garlewicz
Emerging immunoassay-based biomarkers may improve disease assessment and support personalized treatment strategies for patients with atopic dermatitis.
Emerging immunoassay-based biomarkers may improve disease assessment and support personalized treatment strategies for patients with atopic dermatitis.
Emerging immunoassay-based...
11/03/2026
The Dermatologist
Two doctors in a lab
News
Salivary Biomarkers May Offer Noninvasive Approach to Monitoring Atopic Dermatitis
11/03/2026
Jessica Garlewicz
Salivary biomarkers may provide a noninvasive approach to monitoring stress, sleep quality, and disease severity in patients with atopic dermatitis.
Salivary biomarkers may provide a noninvasive approach to monitoring stress, sleep quality, and disease severity in patients with atopic dermatitis.
Salivary biomarkers may provide...
11/03/2026
The Dermatologist
News
Dupilumab Associated With Improved Height Growth and Bone Mineralization Markers in Children With Severe Atopic Dermatitis
11/03/2026
Jessica Garlewicz
Dupilumab treatment was associated with improvements in height growth and bone mineralization markers among children with severe atopic dermatitis.
Dupilumab treatment was associated with improvements in height growth and bone mineralization markers among children with severe atopic dermatitis.
Dupilumab treatment was...
11/03/2026
The Dermatologist
diet
News
Diet May Influence Skin Barrier Function in Atopic Dermatitis
11/02/2026
Coleen Stern, MA
Diet may represent a modifiable factor in skin barrier integrity and atopic dermatitis, but inconsistent findings prevent definitive dietary recommendations.
Diet may represent a modifiable factor in skin barrier integrity and atopic dermatitis, but inconsistent findings prevent definitive dietary recommendations.
Diet may represent a modifiable...
11/02/2026
The Dermatologist
Collagen and vitamin drop skin cell
News
HHS Outlines Conditional Enforcement Discretion for 6 Compounded Peptides
10/29/2026
Coleen Stern, MA
The US Department of Health and Human Services has outlined an interim enforcement policy for compounding 6 peptide bulk drug substances while their inclusion on the section 503A bulks list is considered through rulemaking.
The US Department of Health and Human Services has outlined an interim enforcement policy for compounding 6 peptide bulk drug substances while their inclusion on the section 503A bulks list is considered through rulemaking.
The US Department of Health and...
10/29/2026
The Dermatologist

Popular Articles

Depressed-woman-sitting-on-edge-of-bed
Quiz
Acne and Depressive Symptoms
02/07/2025
In a comparison of the mental health of patients with acne treated with isotretinoin vs oral antibiotics, which treatment group was found to experience more depressive symptoms and psychological distress?
In a comparison of the mental health of patients with acne treated with isotretinoin vs oral antibiotics, which treatment group was found to experience more depressive symptoms and psychological distress?
In a comparison of the mental...
02/07/2025
The Dermatologist
Jeffrey M. Cohen, MD
Conference Coverage
TYK2 as a Therapeutic Target in Psoriasis
08/11/2025
Coleen Stern, MA
Jeffrey M. Cohen, MD, discussed TYK2 inhibitors, a new class of therapy being studied for the treatment of psoriasis.
Jeffrey M. Cohen, MD, discussed TYK2 inhibitors, a new class of therapy being studied for the treatment of psoriasis.
Jeffrey M. Cohen, MD, discussed...
08/11/2025
The Dermatologist
Dr Adam Friedman
Podcasts
The Real Derm: Episode 5, Diving Deep Into the DermPath Pathway: A Candidate's Perspective
07/10/2025
Adam Friedman, MD
Climbing the mountain to get to dermatology residency is bone breaking enough, but what about the next apex, even more specialized training such as a Dermatopathology Fellowship?
Climbing the mountain to get to dermatology residency is bone breaking enough, but what about the next apex, even more specialized training such as a Dermatopathology Fellowship?
Climbing the mountain to get to...
07/10/2025
The Dermatologist
AA Patient with Heart-Shaped Hair Loss Patch examined by doctor
Advancing Alopecia Areata Classification and Care
11/25/2024
  Alopecia areata (AA) is an autoimmune condition in which patients experience varying degrees of hair loss.1 Therefore, estimating severity is crucial for proper diagnosis. Determining the extent of hair loss is essential for...
  Alopecia areata (AA) is an autoimmune condition in which patients experience varying degrees of hair loss.1 Therefore, estimating severity is crucial for proper diagnosis. Determining the extent of hair loss is essential for...
  Alopecia areata (AA)...
11/25/2024
The Dermatologist
psoriatic arthritis
News
Senescent CD8+ T Cells Linked to Pathogenesis in Spondyloarthritis and Psoriatic Arthritis
01/24/2025
Jessica Garlewicz
A recent study highlights the role of terminally differentiated CD8+ T cells in the pathogenesis of radiographic axial spondyloarthritis and psoriatic arthritis.
A recent study highlights the role of terminally differentiated CD8+ T cells in the pathogenesis of radiographic axial spondyloarthritis and psoriatic arthritis.
A recent study highlights the...
01/24/2025
The Dermatologist
october 2026

Current Issue

October 2026
Volume 34
Issue 7
Current Issue
Issue Archive

Latest Quizzes

Quiz
Quiz
Neuroimmune Signaling and Tissue Remodeling in Prurigo Nodularis
11/09/2026
Riya Gandhi, MA
Test your understanding of the complex interactions among inflammatory cytokines, sensory neurons, and tissue remodeling in prurigo nodularis.
Test your understanding of the complex interactions among inflammatory cytokines, sensory neurons, and tissue remodeling in prurigo nodularis.
Test your understanding of the...
11/09/2026
The Dermatologist
Physician with child
Quiz
Pediatric Patients With Atopic Dermatitis Receiving Dupilumab
11/03/2026
Jessica Garlewicz
What proportion of children aged 6 to 11 years with severe atopic dermatitis receiving dupilumab achieved a height increase of at least 5 percentile points after 4 months of treatment?
What proportion of children aged 6 to 11 years with severe atopic dermatitis receiving dupilumab achieved a height increase of at least 5 percentile points after 4 months of treatment?
What proportion of children aged...
11/03/2026
The Dermatologist
magnifying glass in front of stacks of books
Quiz
Therapeutic Response Heterogeneity and Precision Medicine in Type 2 Inflammation
11/02/2026
Riya Gandhi, MA
Evaluate advanced clinical reasoning in targeted treatment selection, unexpected therapeutic responses, and the challenges of precision medicine in inflammatory dermatology.
Evaluate advanced clinical reasoning in targeted treatment selection, unexpected therapeutic responses, and the challenges of precision medicine in inflammatory dermatology.
Evaluate advanced clinical...
11/02/2026
The Dermatologist
Illustration-depicting-knowledge-or-education
Quiz
Neuroimmune Interactions and Disease Persistence in Type 2 Inflammation
11/02/2026
Riya Gandhi, MA
Challenge your understanding of inflammatory feedback mechanisms, neuronal sensitization, and the complex cellular interactions involved in chronic dermatologic disease.
Challenge your understanding of inflammatory feedback mechanisms, neuronal sensitization, and the complex cellular interactions involved in chronic dermatologic disease.
Challenge your understanding of...
11/02/2026
The Dermatologist
Clock for test
Quiz
Understanding Type 2 Inflammation Across Inflammatory Skin Diseases
11/02/2026
Riya Gandhi, MA
Test your clinical understanding of inflammatory disease classification, overlapping immune pathways, and the evolving role of type 2 inflammation in dermatology.
Test your clinical understanding of inflammatory disease classification, overlapping immune pathways, and the evolving role of type 2 inflammation in dermatology.
Test your clinical understanding...
11/02/2026
The Dermatologist
Book with arrows
Quiz
Advanced Therapeutic Sequencing and Personalized Care in Type 2 Inflammatory Skin Disease
10/25/2026
Riya Gandhi, MA
Challenge your understanding of treatment sequencing, biologic failure, JAK inhibitor escalation, and future biomarker-driven approaches in inflammatory dermatology.
Challenge your understanding of treatment sequencing, biologic failure, JAK inhibitor escalation, and future biomarker-driven approaches in inflammatory dermatology.
Challenge your understanding of...
10/25/2026
The Dermatologist
AD
Quiz
Precision Therapeutic Selection Across Type 2 Inflammatory Skin Diseases
10/15/2026
Riya Gandhi, MA
Evaluate your clinical approach to selecting targeted therapies across multiple type 2 inflammatory skin diseases by integrating disease biology, symptom burden, and treatment sequencing.
Evaluate your clinical approach to selecting targeted therapies across multiple type 2 inflammatory skin diseases by integrating disease biology, symptom burden, and treatment sequencing.
Evaluate your clinical approach...
10/15/2026
The Dermatologist
HS
Quiz
Quiz: Efficacy Findings for Povorcitinib in the Phase 3 STOP-HS1 and STOP-HS2 Trials
10/01/2026
Jessica Garlewicz
Which of the following best describes the week 12 efficacy findings for povorcitinib in the phase 3 STOP-HS1 and STOP-HS2 trials in patients with moderate-to-severe hidradenitis suppurativa?
Which of the following best describes the week 12 efficacy findings for povorcitinib in the phase 3 STOP-HS1 and STOP-HS2 trials in patients with moderate-to-severe hidradenitis suppurativa?
Which of the following best...
10/01/2026
The Dermatologist
itch
Quiz
Clinical Implications of Type 2 Inflammation in Chronic Spontaneous Urticaria
09/21/2026
Riya Gandhi, MA
Evaluate your understanding of disease fluctuation, neuroimmune signaling, cytokine biology, and targeted therapeutic strategies in chronic spontaneous urticaria.
Evaluate your understanding of disease fluctuation, neuroimmune signaling, cytokine biology, and targeted therapeutic strategies in chronic spontaneous urticaria.
Evaluate your understanding of...
09/21/2026
The Dermatologist
random molecule
Quiz
Understanding Type 2 Inflammatory Mechanisms in Chronic Spontaneous Urticaria
09/14/2026
Riya Gandhi, MA
Test your understanding of cytokine signaling, mast cell biology, neuroimmune interactions, and the mechanisms that drive chronic spontaneous urticaria.
Test your understanding of cytokine signaling, mast cell biology, neuroimmune interactions, and the mechanisms that drive chronic spontaneous urticaria.
Test your understanding of...
09/14/2026
The Dermatologist

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use